New strategy for overcoming resistance to targeted cancer drug

Researchers have discovered a pair of backup circuits in cancer cells that enable the cells to dodge the effect of cetuximab. Until now, scientists haven't known why cancers that initially respond to cetuximab become resistant to it, or how to overcome such resistance.

Read the whole article on Science Daily

More from Science Daily